Shennon Biotechnologies Raises $13M Seed Financing to Accelerate Immunotherapy Target Discovery with Proprietary Single-Cell Functional Screening Platform
SAN FRANCISCO--(BUSINESS WIRE)--Shennon Biotechnologies Raises $13M to Accelerate Immunotherapy Target Discovery with Proprietary Single-Cell Functional Screening Platform
